Glenmark Pharma submits drug application with USFDA for Ryaltris
"The company has submitted a new drug application (NDA) to the US Food Drug Administration (USFDA) for... respiratory pipeline candidate Ryaltris, an investigational fixed-dose combination nasal spray of an antihistamine and a steroid," Glenmark Pharmaceuticals said in a BSE filing.from Moneycontrol Business News https://ift.tt/2x7n6ie
Comments
Post a Comment